Establishing Atrial Fibrillation Clinics: If not now, When?

Int J Cardiol Cardiovasc Risk Prev

Physician, Dow University of Health Sciences, Karachi, Pakistan.

Published: December 2021

Background And Objectives: Atrial Fibrillation (AFib) is the most common arrhythmia, associated with considerable morbidity and mortality. It affects 8% population and its incidence rises with age. The consequences of untreated or poorly treated Afib are grave, therefore, appropriate management of this condition should occupy high priority.

Discussion: AFib clinic provides a prompt, well-organized, and conclusive approach to managing affected patients. The essence of such a set-up lays in providing frequent monitoring to the patient in well-equipped centres with specialized doctors and trained staff. Worldwide AFib clinics have shown evidence of morbidity, mortality, and cost-benefits.

Conclusion: In developing countries such as Pakistan with less budget granted to health care, specialized AFib clinics could save cost, besides providing better health care outcomes to the patients. It is crucial to establish such focused AFib care centres urgently.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8710408PMC
http://dx.doi.org/10.1016/j.ijcrp.2021.200119DOI Listing

Publication Analysis

Top Keywords

atrial fibrillation
8
morbidity mortality
8
afib clinics
8
health care
8
afib
6
establishing atrial
4
fibrillation clinics
4
clinics when?
4
when? background
4
background objectives
4

Similar Publications

Introduction: The efficacy and safety of statins for secondary prevention in patients who have experienced a cardioembolic stroke are not well-defined. However, previous observational data reported hyperlipidemia as a risk factor for both ischemic and bleeding complications in patients with AF and previous stroke. Based on these premises, we conducted a sub-analysis of the RAF and RAF-NOAC studies to evaluate the efficacy and safety of statins in secondary prevention in patients with acute ischemic stroke and AF.

View Article and Find Full Text PDF

Lipoprotein(a) and Atrial Fibrillation: Mechanistic Insights and Therapeutic Approaches.

Int J Med Sci

January 2025

Department of Cardiology, The Second Xiangya Hospital, Central South University, Changsha 410011, Hunan Province, People's Republic of China.

Elevated lipoprotein(a) [Lp(a)] levels are increasingly recognized as a significant risk factor for cardiovascular diseases and may also contribute to atrial fibrillation (AF). This review investigated the indirect mechanisms through which Lp(a) may influence AF, including proatherogenic, prothrombotic, and proinflammatory pathways. Traditional lipid-lowering therapies, such as lifestyle modifications and statins, have limited effects on Lp(a) levels.

View Article and Find Full Text PDF

Comparison of Catheter Ablation in Patients with Paroxysmal Non-valvular Atrial Fibrillation and Heart Failure with Preserved Ejection Fraction.

Int J Med Sci

January 2025

Department of Cardiology, The Second Xiangya Hospital, Central South University, Changsha 410011, Hunan Province, People's Republic of China.

The efficacy of radiofrequency ablation (RFA) in patients with atrial fibrillation (AF) and heart failure with preserved ejection fraction (HFpEF) has been established, but the efficacy and safety of cryoballoon ablation (CBA) and pulsed field ablation (PFA) remain unclear. This retrospective cohort study included 223 patients with paroxysmal non-valvular AF and HFpEF who underwent their first AF ablation between January 2017 and December 2021 and were divided into RFA (n = 77), CBA (n = 127), and PFA (n = 19) groups. After a mean follow-up of 11.

View Article and Find Full Text PDF

Background Atrial high-rate episodes (AHREs) detected by cardiac implantable electronic devices (CIEDs) are indicative of future clinical atrial fibrillation (AF) and stroke risk. This study aimed to investigate the prevalence of AHREs among Thai patients with CIED implantation and identify associated risk factors. Methods A retrospective observational study enrolled 278 CIED patients with AHREs lasting five minutes to 24 hours, with an average atrial rate ≥ 175 bpm, excluding known clinical AF at device implantation.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!